What investment did Kiran Mazumdar-Shaw announce for Biocon Biologics?

Kiran Mazumdar-Shaw announced a strategic alliance with Biocon Biologics Limited in November 2022, which included Serum Life Sciences making an additional equity investment of $150 million into Biocon Biologics by converting a prior loan. This investment aims to enhance Biocon's position in the biosimilars market.